Literature DB >> 21797822

Role of Toll-like receptors in liver health and disease.

Ruth Broering1, Mengji Lu, Joerg F Schlaak.   

Abstract

TLRs (Toll-like receptors), as evolutionarily conserved germline-encoded pattern recognition receptors, have a crucial role in early host defence by recognizing so-called PAMPs (pathogen-associated molecular patterns) and may serve as an important link between innate and adaptive immunity. In the liver, TLRs play an important role in the wound healing and regeneration processes, but they are also involved in the pathogenesis and progression of various inflammatory liver diseases, including autoimmune liver disease, alcoholic liver disease, non-alcoholic steatohepatitis, fibrogenesis, and chronic HBV (hepatitis B virus) and HCV (hepatitis C virus) infection. Hepatitis viruses have developed different evading strategies to subvert the innate immune system. Thus recent studies have suggested that TLR-based therapies may represent a promising approach in the treatment in viral hepatitis. The present review focuses on the role of the local innate immune system, and TLRs in particular, in the liver.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21797822     DOI: 10.1042/CS20110065

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  33 in total

Review 1.  Immunomodulatory effects of transforming growth factor-β in the liver.

Authors:  Hans-Theo Schon; Ralf Weiskirchen
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 2.  Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.

Authors:  Veerle Bieghs; Christian Trautwein
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 3.  Bloodstream infections in patients with liver cirrhosis.

Authors:  Michele Bartoletti; Maddalena Giannella; Russell Edward Lewis; Pierluigi Viale
Journal:  Virulence       Date:  2016-02-11       Impact factor: 5.882

4.  Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.

Authors:  Silvia Giugliano; Michael Kriss; Lucy Golden-Mason; Evgenia Dobrinskikh; Amy E L Stone; Alejandro Soto-Gutierrez; Angela Mitchell; Salman R Khetani; Daisuke Yamane; Mark Stoddard; Hui Li; George M Shaw; Michael G Edwards; Stanley M Lemon; Michael Gale; Vijay H Shah; Hugo R Rosen
Journal:  Gastroenterology       Date:  2014-11-04       Impact factor: 22.682

Review 5.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  SAMe treatment prevents the ethanol-induced epigenetic alterations of genes in the Toll-like receptor pathway.

Authors:  Ronik Khachatoorian; David Dawson; Eden M Maloney; Julie Wang; Barbara A French; Samuel W French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2012-10-06       Impact factor: 3.362

7.  Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells.

Authors:  Ying-Ju Li; Ping Zhu; Yu Liang; Wei-Guo Yin; Jian-Hua Xiao
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

8.  Testosterone persistently dysregulates hepatic expression of Tlr6 and Tlr8 induced by Plasmodium chabaudi malaria.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel-Azeem S Abdel-Baki; Marcos J Araúzo-Bravo; Denis Delic; Frank Wunderlich
Journal:  Parasitol Res       Date:  2014-07-24       Impact factor: 2.289

9.  Flavanol-Enriched Cocoa Powder Alters the Intestinal Microbiota, Tissue and Fluid Metabolite Profiles, and Intestinal Gene Expression in Pigs.

Authors:  Saebyeol Jang; Jianghao Sun; Pei Chen; Sukla Lakshman; Aleksey Molokin; James M Harnly; Bryan T Vinyard; Joseph F Urban; Cindy D Davis; Gloria Solano-Aguilar
Journal:  J Nutr       Date:  2016-03-02       Impact factor: 4.798

Review 10.  Immune dysfunction in cirrhosis.

Authors:  Nora Sipeki; Peter Antal-Szalmas; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.